Psoriatic Arthritis
From the Journals
Reassurance for women taking certolizumab during pregnancy
Exposure to certolizumab pegol does not appear to be associated with an increased risk of fetal death or congenital malformations.
Daily News Podcast
MDedge Daily News: Does more marijuana mean fewer opioids?
And acutely ill patients may not get enough venous thromboembolism prophylaxis.
From the Journals
Most PsA patients discontinue initial biologic within 12 months
The results “suggest a high frequency of suboptimal biologic experience in patients with PsA.”
News from the FDA/CDC
TB in 2017: Good news and bad news
Incidence is lower than ever, but elimination is still a long way off.
From the Journals
Study using U.K. data quantifies infection risk associated with psoriasis
The most common serious infections were lower respiratory tract, skin and soft tissue, and upper respiratory tract infections.
News
FDA approves certolizumab label update for pregnancy, breastfeeding
Approval is based on data from the CRIB and CRADLE studies.
Latest News
FDA approves IL-23 antagonist for plaque psoriasis
Approval is based on data from two phase 3, identically designed clinical trials, reSURFACE1 and reSURFACE2.
News from the FDA/CDC
Arthritis limits physical activity the most in the South
Physical inactivity rates among arthritis patients ranked highest in southern states.
From the Journals
Ultrasound study supports deep Koebner mechanism in PsA pathology
Digital accessory pulleys are thicker in PsA patients than in those with RA or psoriasis only.
Conference Coverage
PASI responses with biologics similar among white, nonwhite individuals, study finds
MIAMI– Investigators used data from psoriasis studies to determine whether treatment responses differed in skin of color patients.
Conference Coverage
Study highlights need to investigate psoriasis treatment outcomes in skin of color patients
MIAMI – Researchers used phase 2 and 3 psoriasis clinical trial data to explore potential differences in treatment response in various ethnic...